Evidence-Based Neonatal Pain Management In Practice

Neonates experience pain during procedures, illness, surgery, and routine intensive care. Their limited ability to communicate does not reduce the biological effects of pain. Repeated untreated or poorly treated pain can contribute to stress responses, disrupted sleep, feeding difficulties, altered pain sensitivity, and adverse neurodevelopmental effects. Effective care therefore requires deliberate assessment and an individualized plan rather than an assumption that newborns will not remember painful events.

Evidence-based neonatal pain management combines behavioral observation, physiologic monitoring, developmentally supportive care, and carefully selected medication. The goal is not to eliminate every stressful sensation, which is rarely possible in a neonatal unit, but to prevent avoidable pain, reduce procedural distress, and provide timely treatment when discomfort is clinically significant.

These priorities fit the scientific focus of the FAOPS 2020 congress, which brought together perinatal and neonatal specialists around research, clinical practice, and international collaboration. Although the Tokyo meeting was canceled in April 2020 because of the COVID-19 pandemic and travel restrictions, its subject areas remain central to modern newborn care.

Why Pain Recognition Matters In Newborns

Neonates may show pain through facial grimacing, brow bulging, eye squeezing, nasolabial furrowing, crying, limb withdrawal, and changes in muscle tone. Some infants become agitated, while others become unusually still or difficult to console. Premature infants can display less obvious behavioral responses because of immaturity, illness, sedation, or neurologic impairment. A quiet infant is not necessarily a comfortable infant.

Physiologic signs can strengthen an assessment but should not be used alone. Tachycardia, oxygen desaturation, blood pressure changes, altered respiratory pattern, and sweating may accompany pain, yet these findings also occur with hypoxia, sepsis, hypovolemia, or handling. Clinical teams should interpret vital-sign changes alongside behavior, the procedure being performed, baseline condition, and the infant’s response to comfort measures.

Validated neonatal pain scales support consistent documentation. Examples include the Premature Infant Pain Profile-Revised, Neonatal Infant Pain Scale, and Children’s and Infants’ Postoperative Pain Scale. Each tool has a specific population and purpose, so staff should use one consistently, understand its limitations, and record reassessment after an intervention.

Assessment Before, During, And After Procedures

Pain prevention begins before a heel lance, venipuncture, catheter insertion, intubation, dressing change, or other invasive event. The team should identify the anticipated level and duration of pain, review the infant’s medical condition, select pharmacologic and nonpharmacologic measures, and assign responsibility for observation. Clustering care can reduce the number of separate stressful episodes, while allowing adequate recovery between procedures.

During the intervention, one clinician should monitor the infant rather than focusing exclusively on the technical task. Changes in facial expression, motor activity, crying, oxygenation, and heart rate should be compared with the baseline score. If pain escalates, the procedure should pause when clinically safe so that positioning, containment, sucrose, analgesia, or other support can be applied.

Post-procedure reassessment is essential. A treatment cannot be considered successful simply because the procedure was completed. Documenting the pain score, intervention, response, and adverse effects creates a useful clinical record and reveals patterns, such as repeated distress during a particular procedure or insufficient duration of analgesia after surgery. This information supports quality improvement and more precise future care.

Comfort Measures That Reduce Procedural Distress

Developmentally supportive care forms the foundation of neonatal analgesia. Facilitated tucking, swaddling, skin-to-skin contact, nonnutritive sucking, breastfeeding, gentle containment, reduced noise, dimmed lighting, and a calm caregiver can lower behavioral and physiologic signs of procedural pain. These interventions are inexpensive, adaptable, and suitable for many premature and term infants.

Oral sucrose or glucose given shortly before a brief procedure can reduce pain responses in infants who can safely receive oral treatment. It works best when paired with nonnutritive sucking and appropriate positioning. The dose, concentration, timing, and frequency should follow local neonatal protocols, because repeated exposure should be monitored and sucrose should never replace analgesia for major surgery or prolonged pain.

Breastfeeding or expressed breast milk may provide comfort during minor procedures when the infant is clinically stable and oral feeding is safe. Skin-to-skin care can also support thermal regulation, cardiorespiratory stability, and parental involvement. These measures should be offered as part of a structured plan, not treated as a substitute for medication when the expected pain is moderate or severe.

Medication Selection And Safe Dosing

Pharmacologic treatment depends on the procedure, gestational age, organ function, hemodynamic status, and expected duration of pain. Local anesthetics may be useful for selected needle procedures or minor skin interventions, though they require correct timing and administration. Acetaminophen can support mild to moderate pain and postoperative care, but dosing must account for weight, maturity, liver function, route, and total daily exposure.

Opioids may be appropriate for severe pain, mechanical ventilation-related distress, or major surgery. Morphine and fentanyl are commonly used in neonatal settings, but both require close monitoring. Respiratory depression, hypotension, chest-wall rigidity with rapid fentanyl administration, urinary retention, ileus, and tolerance are clinically important risks. Infusions should be reassessed regularly, and prolonged treatment requires a withdrawal-prevention and weaning plan.

Sedation is not equivalent to analgesia. A sedated infant may still experience pain, while some sedatives can impair respiratory drive or cardiovascular stability. Benzodiazepines, in particular, should not be used as routine pain treatment in newborns without a clear indication and specialist oversight. Every medication order should state the indication, route, dose, interval, monitoring requirements, and criteria for stopping or adjusting treatment.

Prematurity, Surgery, And Critical Illness

Premature infants have immature neurologic and metabolic systems, but this does not mean they are insensitive to pain. They may have limited energy reserves and atypical behavioral signals, making repeated assessment especially important. Medication clearance can vary substantially with gestational and postnatal age, so standard term-infant doses may produce excessive exposure in a very premature infant.

Critically ill neonates often experience several overlapping sources of discomfort: ventilation, vascular access, chest tubes, surgery, inflammation, immobility, and frequent handling. A pain score should be considered alongside sedation assessment, delirium risk, respiratory status, and the underlying disease. Treatment should target the cause where possible, such as correcting an ill-fitting device or reducing unnecessary stimulation.

Perioperative plans should begin before surgery and continue through recovery. Regional anesthesia, local techniques, acetaminophen, carefully titrated opioids, and nonpharmacologic care may be combined according to the procedure and the infant’s condition. The plan should specify who will assess pain, how often reassessment occurs, and how treatment will change if the infant develops hypotension, apnea, excessive sedation, or escalating pain.

Neonatal teams also need a broad view of infection-related and inflammatory illness. Discussions of newborn care during the pandemic, including this SARS-CoV-2 transmission review, illustrate how rapidly clinical assumptions can change as evidence develops. Isolation procedures and parental separation may add stress, so safe family contact, clear communication, and humane handling remain important parts of supportive care.

Building A Reliable Unit-Wide Practice

A strong neonatal pain program makes comfort and analgesia routine responsibilities rather than choices left to individual preference. The unit should define which procedures require assessment, which interventions are first-line, when medication is mandatory, and how effectiveness and adverse effects are recorded. Standardized order sets can reduce omissions while preserving clinician judgment for complex cases.

Education should include nurses, physicians, respiratory therapists, pharmacists, surgeons, and parents. Staff need practical training in pain-scale scoring, facilitated tucking, sucrose administration, medication safety, and recognition of opioid toxicity or withdrawal. Parents can be shown how to provide voice, touch, skin-to-skin care, and nonnutritive comfort when appropriate.

Audits can measure the percentage of painful procedures with documented assessment, use of preventive strategies, reassessment after intervention, opioid exposure, and unplanned adverse events. Reviewing these data in a nonpunitive setting helps identify whether a protocol is being followed and whether it produces meaningful improvement. Research priorities include long-term outcomes, individualized dosing for extremely premature infants, and better tools for infants who are ventilated, sedated, or neurologically impaired.

Practical Priorities For The Bedside

• Anticipate pain before every invasive procedure and choose an intervention based on expected intensity.
• Use a validated neonatal pain scale consistently, recording baseline and post-intervention scores.
• Combine developmental care, containment, sucking, breast milk, breastfeeding, or skin-to-skin contact with medication when indicated.
• Treat analgesia and sedation as separate clinical goals, with explicit monitoring for respiratory and cardiovascular effects.
• Review repeated procedures and cumulative drug exposure during daily rounds, then adjust the care plan as the infant’s condition changes.

Evidence-based care becomes meaningful when it is visible in every bedside decision: fewer avoidable procedures, earlier recognition of distress, thoughtful comfort measures, safe dosing, and documented reassessment. Neonatal clinicians can translate current research into a calmer, safer experience for infants and families by making pain prevention part of routine practice.

Use local protocols, validated assessment tools, pharmacy guidance, and specialist consultation to establish a consistent neonatal pain pathway. Begin with the next procedure, assess the infant before and after it, and carry the learning forward into the unit’s continuing quality-improvement work.